Long-acting pharmacotherapies targeting incretin hormones like glucagon-like peptide-1 (GLP-1) and glucose-dependent ...

A new study has found that Mounjaro may not only be good at treating diabetes, but could actually help prevent the disease.

SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

In an international trial of 713 adults in nine countries including the U.S. called SUMMIT, participants with heart failure ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...

Medically reviewed by Danielle Weiss, MD After losing extra pounds on Ozempic (semaglutide), some are finding themselves ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Garner, MD, Medical Director at SimpleFixRx to review it all for accuracy. Dr, Garner said, "Glucagon-like peptide-1 (GLP-1) ...